CD4 and synovial sarcoma: Studies conducted by flow cytometry tests on CD4+ T cells population identified a specific phenotype (CD26− or CD7− T cells with bright or dim CD3 or CD4 or bright CD7) that represents the phenotype for diagnosis of Sézary syndrome (SS) and mycosis fungoides and correlates with disease progression [30,31].